Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroders Regulatory News (SOI)

Share Price Information for Schroders (SOI)

Share Price is delayed by 15 minutes
Get Live Data
453.00    -6.00 (-1.31%)
Bid:
453.00
Ask:
455.00
Spread: 2.00 (0.442%)
Market Cap: £1.01b
SOI Live PriceLast checked at - London Stock Exchange

Intraday Schroders Share Chart

Results analysis from Kepler Trust Intelligence

22 May 2025 15:44

RNS Number : 8522J
Schroder Oriental Income Fund Ltd
22 May 2025
 

Schroder Oriental Income (SOI)

22/05/2025

Results analysis from Kepler Trust Intelligence

Schroder Oriental Income (SOI) has released its interim results for the six months ending 28/02/2025. Over the period, the trust saw a NAV total return of 2.5%, compared to a return of 10.4% for the trust's benchmark, the MSCI AC Pacific ex Japan Index.

Relative performance was affected by manager Richard Sennitt's underweight to China, although he narrowed this by adding to some of the country's highest-quality names in the weakness. The manager also initiated an off-benchmark position in Indian company Power Grid in the period.

To offset the China risk, Richard is overweight Hong Kong which was a positive, as was stock selection in Taiwanese tech, plus an overweight to both Singapore and financials.

Long-term returns remain strong, with a five-year return more than double that of the index to the end of the period. Since then, the region has been hit by tariff-induced volatility although SOI has delivered positive absolute returns since.

Revenue was down slightly versus last year, albeit just by 1.3%. SOI typically pays an increased final dividend each year which, should it be raised again, will lead to the AIC's dividend hero status. The trust has substantial reserves which the board has indicated could be used to support this.

Gearing remains stable across the period and contributed a small net positive to performance.

New chairman, Nick Winsor, reflected on navigating the region's challenges, stating: "Our strategy of investing in income producing companies with strong balance sheets that can successfully navigate these challenges has never felt more relevant."

Kepler View

Schroder Oriental Income (SOI) has a strong long-term track record of cumulative outperformance of the benchmark. Despite this, the short-term period covered by these results was more challenging. However, considering the rally in SOI's key underweight, China and growth outperforming value, we believe the positive absolute return should be viewed favourably. This is especially true when considering the strong share price returns led to the discount narrowing. Furthermore, performance post period end has been strong, with SOI having navigated the volatility post-Liberation day well.

The board has indicated it wishes to extend the dividend growth track record to 20 years, and therefore achieve the AIC's 'dividend hero' status. Should it do so, it will be the first Asian focussed trust to achieve the feat. The trust has sizeable reserves to help support this.

The changes amongst peers is also interesting, in our view. Several peers have adopted some form of enhanced dividend strategy, leaving SOI as a rare 'natural' income payer. As such, the trust's portfolio profile may diverge from peers going forward due to the valuation-discipline required. We believe the trust could therefore offer important portfolio diversification benefits in the future.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGZKDZZGKZM
Date   Source Headline
27th Nov 202511:42 amRNSNet Asset Value(s)
27th Nov 20259:00 amRNSPortfolio Update
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20255:53 pmRNSDirector/PDMR Shareholding
26th Nov 202511:42 amRNSNet Asset Value(s)
25th Nov 202511:49 amRNSNet Asset Value(s)
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 202511:47 amRNSNet Asset Value(s)
21st Nov 20255:45 pmRNSTransaction in Own Shares
21st Nov 202511:51 amRNSNet Asset Value(s)
20th Nov 202511:42 amRNSNet Asset Value(s)
19th Nov 202511:40 amRNSNet Asset Value(s)
18th Nov 20255:34 pmRNSTransaction in Own Shares
18th Nov 202511:32 amRNSNet Asset Value(s)
17th Nov 20256:24 pmRNSTransaction in Own Shares
17th Nov 202511:49 amRNSNet Asset Value(s)
14th Nov 20255:54 pmRNSTransaction in Own Shares
14th Nov 202511:23 amRNSNet Asset Value(s)
13th Nov 20255:18 pmRNSTransaction in Own Shares
13th Nov 202511:43 amRNSNet Asset Value(s)
12th Nov 202511:29 amRNSNet Asset Value(s)
11th Nov 20255:24 pmRNSTransaction in Own Shares
11th Nov 20254:54 pmRNS-RResults analysis from Kepler Trust Intelligence
11th Nov 202511:51 amRNSNet Asset Value(s)
10th Nov 20255:44 pmRNSTransaction in Own Shares
10th Nov 20255:40 pmRNSAnnual Financial Report on NSM
10th Nov 202512:00 pmRNSNet Asset Value(s)
7th Nov 20255:26 pmRNSTransaction in Own Shares
7th Nov 202511:43 amRNSNet Asset Value(s)
7th Nov 20257:01 amRNSDividend Declaration
7th Nov 20257:00 amRNSFinal Results
6th Nov 202511:41 amRNSNet Asset Value(s)
5th Nov 202512:20 pmRNSNet Asset Value(s)
4th Nov 20255:43 pmRNSTransaction in Own Shares
4th Nov 202511:43 amRNSNet Asset Value(s)
3rd Nov 20255:13 pmRNSTransaction in Own Shares
3rd Nov 202512:28 pmRNSNet Asset Value(s)
31st Oct 20255:13 pmRNSTotal Voting Rights
31st Oct 20254:56 pmRNSTransaction in Own Shares
31st Oct 202511:59 amRNSNet Asset Value(s)
30th Oct 20255:05 pmRNSTransaction in Own Shares
30th Oct 202511:49 amRNSNet Asset Value(s)
29th Oct 20255:25 pmRNSTransaction in Own Shares
29th Oct 202511:49 amRNSNet Asset Value(s)
28th Oct 202511:07 amRNSNet Asset Value(s)
27th Oct 202511:36 amRNSNet Asset Value(s)
24th Oct 202511:35 amRNSNet Asset Value(s)
23rd Oct 20255:19 pmRNSTransaction in Own Shares
23rd Oct 202511:23 amRNSNet Asset Value(s)
22nd Oct 20255:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.